GlassScriptPhysician profile
Zoe Ortega
NPI 1770963258
$2,194.43
in general payments reported to CMS, 2019-2025
16 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $559 · 2021: $350 · 2022: $140 · 2023: $244 · 2024: $190 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $607.31 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $305.11 | 2019-2023 | Tezspire |
| Medtronic, INC. | $272.90 | 2021-2025 | Azure Xt Dr Mri Surescan, Attain Command + Surevalve, Selectsecure |
| Novartis Pharmaceuticals Corporation | $194.49 | 2019-2025 | |
| Abiomed | $162.33 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $134.52 | 2019-2021 | |
| Amgen INC. | $119.76 | 2019-2024 | Repatha |
| Esperion Therapeutics, INC. | $77.17 | 2021 | |
| Boston Scientific Corporation | $72.82 | 2022-2024 | Bodyguardian |
| Merck Sharp & Dohme LLC | $66.01 | 2022-2023 | Verquvo |
| Medtronic Vascular, INC. | $62.13 | 2020 | |
| Pfizer INC. | $47.82 | 2019-2020 | |
| Acacia Pharma INC | $24.31 | 2022 | |
| Astellas Pharma US INC | $20.93 | 2020 | |
| Cardiovascular Systems INC. | $14.72 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoe Ortega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.